VANCOUVER: Havn Life Sciences Inc. has entered into a definitive agreement to acquire all of the outstanding share capital of GCO Packaging and Manufacturing Ltd., which operates a large scale manufacturing, packaging and distribution facility, in British Columbia, in exchange for 6.0 million common shares of HavnLife.

HavnLife intends to utilize the GCO facility to support formulation and manufacturing processes in-house to ensure the highest standards of quality and efficacy.

The acquisition is expected to enable Havn Life to accelerate and scale production of new formulations and products at a single location.

“Having the ability to manufacture natural healthcare products in house will be absolutely critical for us,” noted Tim Moore, Chief Executive Officer of Havn Life.

“The Facility is expected to provide a full suite of in-house manufacturing capabilities, thereby expanding the Company’s potential to capture margins and revenues through vertical integration and expansion of our portfolio into additional product categories.”

Scheduled to launch this spring, the Company’s retail product line will include seven natural health products which support immune health, fatigue, memory, focus and overall brain function.

With the arrival of this set of products, Havn Life will take a major step forward in its mission of providing naturally-derived and standardized products to support human optimization.

Havn Life Sciences earns Health Canada approval for natural health product formulations

Chief Science Officer, Gary Leong noted, “We’re excited to introduce our first seven products this spring, and we’re expecting the acquisition of this facility to set us up to continue developing innovative new formulations and to effectively get innovative products to market. Having worked in the natural health industry for over 20 years, I believe it is vital for Havn Life to integrate its retail division vertically.”

With over 16,000 square feet of space, the Facility features a large warehouse with multi-level inventory racking, fully-equipped and functioning production and packaging rooms, and modern, fully-furnished boardroom, laboratory, and offices.

GCO facility currently holds USDA Organic, Canadian Organic and Kosher certifications, and a large loading area for easy delivery vehicle access.

The closing of the acquisition is expected to occur in or around 10 days.

Havn Life Sciences is a biotechnology company on a mission to unlock human potential using evidence-informed research.

The Company is focused on standardized, quality-controlled extraction of psychoactive compounds from plants and fungi, and the development of natural health care products from non-regulated compounds. www.havnlife.com